<DOC>
	<DOCNO>NCT00156377</DOCNO>
	<brief_summary>In order evaluate effect eliminate nasal carriage mupirocin prophylaxis subsequent Staphylococcus aureus infection , prospective randomize trial perform particularly include patient predispose risk factor S. aureus infection .</brief_summary>
	<brief_title>Prophylaxis With Intranasal Mupirocin Prevention S. Aureus Infections</brief_title>
	<detailed_description>In past study , show strong correlation strain colonize anterior naris , strain isolate presumed foci infection , strain isolate blood patient Staphylococcus aureus bacteremia . These result suggest substantial proportion case systemic S. aureus infection appear endogenous origin eradication nasal colonization chief strategy reduce incidence hospital-acquired S. aureus infection . In order evaluate effect eliminate nasal carriage mupirocin prophylaxis subsequent S. aureus infection , prospective randomize trial perform particularly include patient predispose risk factor S. aureus infection . All patient admit select unit clinic anaesthesiology , hemato-oncology , cardiac surgery , orthopedics University Hospital Muenster regularly screen nasal carriage , i.e . admission , subsequently , weekly basis . S. aureus carry patient prospectively randomize , either treat mupirocin 5 day , leave untreated . Patients infect S. aureus admission patient detect MRSA carrier exclude randomization . Patients regularly see course hospital stay predisposing/conditional risk factor systematically document . In group ( untreated patient patient mupirocin prophylaxis ) , nosocomial infection document accord CDC guideline . If infect , specimens take microbiological diagnosis . All S. aureus isolates ( anterior naris well focus infection ) collect genotyped .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Cross Infection</mesh_term>
	<mesh_term>Mupirocin</mesh_term>
	<criteria>All patient admit select unit clinic anaesthesiology , hematooncology , cardiac surgery , orthopedics University Hospital Muenster ( follow information study agreement patient ) . Patients infect S. aureus admission S. aureus infection within 48 hour follow admission Patients detect carrier Methicillinresistant S. aureus Hospital stay shorter 72 hour Patients anatomic abnormality anterior naris Allergy hypersensitivity mupirocin substance nasal ointment Persons young 18 year Known pregnancy Persons psychiatric disease Persons limit contractual capability judiciousness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Mupirocin</keyword>
	<keyword>Staphylococcus aureus</keyword>
	<keyword>Nasal Cavity</keyword>
	<keyword>Preventive measure</keyword>
</DOC>